Drugs already approved to treat malaria might be effective in treating the symptoms of mild-to-moderate cases of the coronavirus, according to multiple reports.
The United States Food & Drug Administration announced Thursday that they were investigating the usage of the drug chloroquine to treat mild-to-moderate COVID-19 cases.
Chloroquine has already been approved to treat malaria, lupus, and rheumatoid arthritis, with the FDA stating that they hope it can be used to “potentially reduce the duration of symptoms, as well as viral shedding, which can help prevent the spread of disease.”
“Studies are underway to determine the efficacy in using chloroquine to treat COVID-19,” explained the FDA. “While there are no FDA-approved therapeutics or drugs to treat, cure or prevent COVID-19, there are several FDA-approved treatments that may help ease the symptoms from a supportive care perspective.”
French researchers also published a recent study which found that hydroxychloroquine, sold under the brand name Plaquenil, might also help in treating COVID-19.
Amanda Woods of the New York Post reported Wednesday on the study, which was led by Didier Raoult of l’Institut Hospitalo-Universitaire in Marseille.
The study had 36 participants, comprised of 20 treated persons and 16 infected controls, in which the treated group was given 600 mg of Plaquenil daily.
Click here to read more.
SOURCE: Christian Post, Michael Gryboski